Immedica Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Ammonaps | Phenylbutyric acid | 1999-12-07 | ||
| Emadine | Emedastine | 1999-01-27 | ||
| Ravicti | Glycerol phenylbutyrate | 2015-11-26 | 2030-2032 | |
| Ztalmy | Ganaxolone | 2022-06-01 | 2026-2037 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use